xaliproden has been researched along with Peripheral Nerve Diseases in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barton, D; Grothey, A; Kottschade, L; Loprinzi, C; Wolf, S | 1 |
Susman, E | 1 |
D'Orazio, A; Gibson, TB; Ranganathan, A | 1 |
Bougault, I; Coudé, FX; Fournier, J; Gauthier, T; Guzzi, U; Keane, PE; Le Fur, G; Maffrand, JP; Soubrié, P; Steinberg, R | 1 |
1 review(s) available for xaliproden and Peripheral Nerve Diseases
Article | Year |
---|---|
Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
Topics: Acetylcarnitine; Acetylcysteine; Anticonvulsants; Antidepressive Agents, Tricyclic; Antineoplastic Agents; Baclofen; Calcium; Glutamine; Humans; Infusions, Intravenous; Ketamine; Magnesium; Naphthalenes; Nootropic Agents; Paclitaxel; Peripheral Nervous System Diseases; Pyridines; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
3 other study(ies) available for xaliproden and Peripheral Nerve Diseases
Article | Year |
---|---|
Xaliproden lessens oxaliplatin-mediated neuropathy.
Topics: Antineoplastic Agents; Colonic Neoplasms; Humans; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridines | 2006 |
Highlights From: the 2006 American Society of Clinical Oncology Gastrointestinal Cancers Symposium San Francisco, CA, January 2006.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Clinical Trials as Topic; Colorectal Neoplasms; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Neoplasms; Humans; Naphthalenes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Pyridines; Serotonin Receptor Agonists | 2006 |
Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates.
Topics: Acetylcholinesterase; Acrylamide; Acrylamides; Animals; Biomarkers; Brain Ischemia; Callithrix; Choline O-Acetyltransferase; Female; Hippocampus; Male; Naphthalenes; Nerve Crush; Nerve Degeneration; Nerve Growth Factors; Nerve Regeneration; Nerve Tissue Proteins; Peripheral Nervous System Diseases; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Serotonin; Sciatic Nerve; Septum Pellucidum; Serotonin Receptor Agonists; Species Specificity; Vincristine | 1993 |